Versiti

Versiti Blood center with locations in Illinois, Indiana, Michigan, Wisconsin, and Ohio.

Deep Expertise, Broad Reach
Versiti is a strategic affiliation of successful healthcare organizations whose vision is to improve the health of patients as the national leader in innovative transfusion solutions for healthcare systems. Everyone in our nation’s healthcare system is seeking new and better ways to provide high-quality patient care at an affordable cost. Organizations that offer vital

resources must also look at new models of operating that will continually improve patient outcomes, increase the quality of service, and reduce the cost of healthcare. Working together, Versiti offers hospitals a more comprehensive range of services, including transfusion medicine, transplantation, stem cell and cellular therapies, hematology, oncology and genomics. We are passionate about improving the lives of our patients and hospital partners. We apply our deep expertise in blood-related service to solve the toughest challenges Our expertise and resources lead to new products, solutions and services to meet patient and hospital needs.

Paul showed up for his first blood donation because his friend Scott invited him.Scott showed up for his first because h...
04/27/2026

Paul showed up for his first blood donation because his friend Scott invited him.

Scott showed up for his first because his wife, who works in healthcare, encouraged him.

Together, they turned Paul’s inaugural donation into a moment of hope we will remember.

Paul, congrats on your first lifesaving gift. Scott, thanks for leading the way. We are grateful for both of you and for the lives you are already helping. ❤️🩸

Hope doesn’t wait — and neither does John. He rolls up his sleeve again and again to be a lifeline for families. John gi...
04/18/2026

Hope doesn’t wait — and neither does John. He rolls up his sleeve again and again to be a lifeline for families.

John gives more than platelets — he gives patients with leukemia a fighting chance. Every donation is a lifeline that keeps hope beating when it matters most, helping families fight another day.

Join him; donate today at Versiti and be your community’s lifeline. Schedule your appointment at Versiti.org.

It's Breakthrough Friday, your weekly look at the science transforming futures for patients who can't wait. This week: a...
04/17/2026

It's Breakthrough Friday, your weekly look at the science transforming futures for patients who can't wait.

This week: a finding that could change how sickle cell gene therapy is designed.

Scientists knew that a protein called fetal hemoglobin can protect sickle cell warriors. What they didn't know is that it matters how evenly that protein is distributed across a patient's cells, not just how much of it is there on average.

VBRI's Dr. Phillip Doerfler and colleagues found that patients with consistent fetal hemoglobin across all their cells had no symptoms, whereas those with uneven levels experienced pain events, even when their average levels were similar.

Precision medicine starts with discoveries like this one. Invest in Hope powers them. Investinhope.versiti.org

For some hospitalized patients, a medication designed to prevent blood clots can trigger a dangerous immune response tha...
04/16/2026

For some hospitalized patients, a medication designed to prevent blood clots can trigger a dangerous immune response that causes clotting instead. It's rare, but it's life-threatening. And VBRI Senior Investigator and Program Co-Leader Dr. Renren Wen has spent years working to understand why.

Her NIH-funded research into heparin-induced thrombocytopenia and a recent study identifying why some COVID-19 patients develop dangerous clotting complications are building the science that could one day protect the most vulnerable patients in our hospitals.

Patients count on us. Relentless research answers the call. This is Invest in Hope.

Read more at investinhope.versiti.org

𝗪𝗼𝗺𝗲𝗻 𝗥𝗼𝗰𝗸𝗶𝗻𝗴 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 is back at Versiti Blood Research Institute.Join us for an inspiring evening celebrating women in...
04/15/2026

𝗪𝗼𝗺𝗲𝗻 𝗥𝗼𝗰𝗸𝗶𝗻𝗴 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 is back at Versiti Blood Research Institute.

Join us for an inspiring evening celebrating women in science and the research shaping better health for all of us.

You’ll hear from Lisa Baumann Kreuziger, MD, MS, Senior Medical Director of Hematology at Versiti, as she shares the work behind 𝗩𝗘𝗡𝗨𝗦: the nation’s only clinical trial network dedicated solely to venous thrombosis.

Register to attend:
https://bit.ly/4mv92E8

Hope. It’s in Our Blood.

James was diagnosed with sickle cell disease at age two. He spent years of his childhood in and out of hospitals, enduri...
04/15/2026

James was diagnosed with sickle cell disease at age two. He spent years of his childhood in and out of hospitals, enduring pain he describes as "a jackhammer going through my body," infections, surgeries, and milestones marked from a hospital bed.

He's 44 now. He works as a medical assistant at Children's Hospital, showing up every day for patients who need the kind of care he once depended on.

James is one of approximately 100,000 sickle cell warriors in the United States. He is the reason research can't wait.

VBRI’s world-class researchers identify the genetic variations that put some sickle cell warriors at greater risk of life-threatening complications while also making groundbreaking discoveries that hold the keys to improving treatment options for patients nationwide. VBRI is purpose-built for patients like James.

investinhope.versiti.org

Platelets are small, but their role is enormous. These tiny blood cells stop bleeding in surgeries, cancer treatments, a...
04/14/2026

Platelets are small, but their role is enormous.

These tiny blood cells stop bleeding in surgeries, cancer treatments, and trauma care every single day. For patients whose bodies struggle to produce them, they can be the difference between life and death.

VBRI researcher Dr. Hervé Falet has dedicated his career to understanding how platelets form and what happens when that process goes wrong. His NIH-funded research is building the foundation for better treatments for patients who depend on healthy platelet production.

This is the foundational science Invest in Hope is built to support. Because every future breakthrough stands on the work happening right now. Investinhope.versiti.org

"I wanted to personally thank you for your recent blood donation. My 4-year-old daughter was diagnosed with a stage 4 di...
04/12/2026

"I wanted to personally thank you for your recent blood donation. My 4-year-old daughter was diagnosed with a stage 4 diffuse anaplastic Wilms Tumor. It's a type of highly aggressive kidney cancer that requires very aggressive chemotherapy."

💚 Donated recently? Share a photo in the comments—we’d love to celebrate you!

Hope. It’s in Our Blood.

It's Breakthrough Friday, your weekly look at the life-changing science happening at Versiti Blood Research Institute. ...
04/10/2026

It's Breakthrough Friday, your weekly look at the life-changing science happening at Versiti Blood Research Institute.

Did you know that platelets stored for transfusion slowly lose their clotting strength? For patients who need a transfusion after surgery or chemotherapy, that matters.

VBRI researchers Dr. Peter Newman, Dr. Alyssa Moroi, and Cathy Paddock have developed an antibody that restores clotting power in platelets, potentially extending the shelf life of stored units and making every transfusion more effective for the patients who depend on it most.

Lab to life. That's what Invest in Hope builds. Investinhope.versiti.org

Most multiple myeloma patients are told they'll manage this disease for the rest of their lives. A recent study by VBRI ...
04/09/2026

Most multiple myeloma patients are told they'll manage this disease for the rest of their lives. A recent study by VBRI researchers aims to provide a different answer.

By studying patients who achieved long-term survival, the study, authored by Khanmi Kasomva, PhD, and co-led by VBRI Senior Investigator and Interim Co-Director Sid Rao, MD, PhD, found that their immune systems share distinct strengths: better T-cell activity, stronger natural killer cells, and fewer cells that suppress the immune response. That immune environment appears to hold the cancer in check.

If we can create that environment intentionally, more patients could achieve sustained remission, rather than just longer management. Families deserve answers today. That's why relentless research can't wait.

Invest in Hope powers this work. Investinhope.versiti.org

04/08/2026

Wade Sugden watches, in real time, a single cell transform inside a zebrafish embryo. One moment, it was part of a blood vessel wall. The next, it was something else entirely: a hematopoietic stem cell, the kind that will one day produce every blood cell a person ever needs. The kind that powers life-saving bone marrow transplants for patients with leukemia and sickle cell disease.

His NIH-funded research now focuses on how blood flow itself shapes that remarkable transformation and whether we can use that knowledge to grow more of these cells for patients awaiting a transplant.

This is My Spark — the moment that makes a researcher refuse to stop asking why. Invest in Hope fuels what comes next.

Investinhope.versiti.org

Address

638 North 18th Street
Milwaukee, WI
53233

Website

Alerts

Be the first to know and let us send you an email when Versiti posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category